Siilo provides a secure, compliance-focused messaging and collaboration platform for healthcare professionals. Its free Siilo Messenger lets individuals and teams coordinate patient care, expand professional networks, and exchange best practices, while Siilo Connect is a subscription service for hospitals, care organizations, and medical associations to facilitate staff-wide case collaboration and external consultations. The company emphasizes regulatory compliance, including GDPR, ISO-27001, HIPAA and NHS standards, to enable use inside clinical institutions. Siilo Connect is used at institutions such as East Lancashire Hospitals NHS Trust, Erasmus Medical Centre Rotterdam, and Charité in Berlin. Founded in 2016 by Joost Bruggeman (CEO) and Arvind Rao (CFO) and based in Amsterdam, Siilo plans to expand its product offering to better support case-based collaboration and knowledge-sharing. The company also intends to grow its network across the UK & Ireland, DACH, and Benelux and to hire talent in product development and customer success. Siilo provides a secure instant messaging app designed for healthcare professionals, keeping personal and professional data separate on the device and storing patient information in an encrypted vault. Content is not automatically backed up to the cloud and messages are deleted every 30 days unless users request otherwise. The app enables medical teams to manage workflow, securely collaborate on patient treatments, and consult a verified user base for broader expertise. Siilo reports over 7.5 million messages processed per month and more than 100,000 users across institutions such as St. George’s Hospital, London, and Charité Berlin. Founded in 2016, the company has seen organic adoption in smaller teams in California and transplantation teams in Astana, Kazakhstan. It plans to use the new funding to scale its user base across Europe, with particular focus on the UK and Germany.

Total raised

$16M

Funding rounds

2

Latest round

Series A

Latest activity

Jul 2020